DT
SNDX icon

Diversified Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

Diversified Trust’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
32,420
+18,760
+137% +$390K 0.01% 635
2026
Q1 		$319K Buy
13,660
+2,551
+23% +$55.4K 0.01% 829
2025
Q4 		$233K Buy
+11,109
New +$194K ﹤0.01% 918
2024
Q2 		– Sell
-15,523
Closed -$369K – 936
2024
Q1 		$369K Buy
+15,523
New +$346K 0.01% 596

Other funds holding SNDX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
HPBT
Hickory Point Bank & Trust Decatur, Illinois $165M AUM 27.01% 1-Year Est. Return

Diversified Trust's SNDX Position: Q2 2026 in Review

Diversified Trust increased its Syndax Pharmaceuticals (SNDX) stake by 137% in Q2 2026, buying an estimated $390K and bringing the position to 32,420 shares worth $709K. The position accounts for 0.01% of the portfolio, ranked #635.

Diversified Trust first reported a position in SNDX in Q1 2024 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Diversified Trust held 32,420 shares of Syndax Pharmaceuticals worth $709K as of Q2 2026.
  • Diversified Trust bought 18,760 Syndax Pharmaceuticals shares in Q2 2026, an estimated $390K.
  • Syndax Pharmaceuticals made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #635 holding.
  • Diversified Trust first reported a position in Syndax Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.